The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

QR Code

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

Coconut, Cocos nucifera L., is a tree that is cultivated to provide a large number of products, although it is mainly grown for its nutritional and medicinal values. Coconut oil, derived from the coconut fruit, has been recognised historically as containing high levels of saturated fat; however, clo...

Full description

Bibliographic Details
Main Authors:	Fernando, W., Martins, I., Goozee, K., Brennan, C., Jayasena, Vijay, Martins, R.
Format:	Journal Article
Published:	Cambridge University Press 2015
Online Access:	http://hdl.handle.net/20.500.11937/30671

Similar Items

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
by: Goozee, K., et al.
Published: (2015)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Yeast as a model for studying Alzheimer's disease
by: Bharadwaj, Prashant, et al.
Published: (2010)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk
by: Takechi, Ryu, et al.
Published: (2010)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier
by: Asih, P., et al.
Published: (2017)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction
by: Foster, Jonathan, et al.
Published: (2008)

Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's disease
by: Trifunovic, J., et al.
Published: (2017)

The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

Polyphenolic tea catechins : health promotion, disease prevention and molecular mechanisms of action
by: Umar, Kabir Mustapha, et al.
Published: (2012)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

PHARMACOLOGICAL EVALUATION OF NOVEL COMPOUNDS AS ALZHEIMER’S DISEASE TREATMENT
by: Li, Tian-Tian
Published: (2024)

Dietary prevention of chronic obstructive pulmonary disease
by: Hirayama, F., et al.
Published: (2013)

Dietary Prevention of Chronic Obstructive Pulmonary Disease
by: Hirayama, Fumi, et al.
Published: (2012)

Potential of phytochemicals as a treatment for Alzheimer’s disease: evaluation of anticholinesterase activity, antioxidant properties, and cytotoxicity
by: Aljadaan, Adel
Published: (2025)

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
by: Burnham, S., et al.
Published: (2016)

A study of the neurodegenerative mechanisms of Alzheimer’s and Huntington’s diseases
by: Parry, Nicholas
Published: (2016)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
by: Gnjec, A., et al.
Published: (2008)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

The structure and function of Alzheimer's gamma secretase enzyme complex
by: Krishnaswamy, S., et al.
Published: (2009)

Herbal medicine: a promising approach for the treatment of Alzheimer's disease
by: Vishnumukkala, Thirupathirao, et al.
Published: (2024)

Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats
by: D'Alonzo, Zachary, et al.
Published: (2023)

Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

Alzheimer's disease talk
by: The Star,
Published: (2012)

Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2015)

Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?
by: Sharman, M., et al.
Published: (2019)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hvgn9r2aerrcojdb52i84a6bjd